V Region Carbohydrate and Antibody Expression
Overview
Authors
Affiliations
N-Linked carbohydrates are frequently found in the V region of Ig H chains and can have a positive or negative effect on Ag binding affinity. We have studied a murine anti-alpha(1-->6) dextran V(H) that contains a carbohydrate in complementarity-determining region 2 (CDR2). This carbohydrate remains high mannose rather than being processed to a complex form, as would be expected for glycans on exposed protein loops. We have shown that the glycan remained high mannose when murine-human chimeric Abs were produced in a variety of cell types. Also, when another carbohydrate was present in CDR1, CDR2, or CDR3 of the L chain, the V(H) CDR2 glycan remained high mannose. Importantly, we found that when the anti-dextran V(H) CDR2 replaced CDR2 of an anti-dansyl V(H), the glycosylation site was used, but H chains were withheld in the endoplasmic reticulum and did not traffic to the Golgi apparatus. These results suggest that inappropriate V region glycosylation could contribute to ineffective Ab production from expressed Ig genes. In some cases, a carbohydrate addition sequence generated by either V region rearrangement or somatic hypermutation may result in an Ab that cannot be properly folded and secreted.
Panagides N, Zacchi L, De Souza M, Morales R, Karnowski A, Liddament M Int J Mol Sci. 2022; 23(15).
PMID: 35955604 PMC: 9369378. DOI: 10.3390/ijms23158470.
Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation.
Mimura Y, Saldova R, Mimura-Kimura Y, Rudd P, Jefferis R Exp Suppl. 2021; 112:481-517.
PMID: 34687020 DOI: 10.1007/978-3-030-76912-3_15.
Mimura Y, Katoh T, Saldova R, OFlaherty R, Izumi T, Mimura-Kimura Y Protein Cell. 2017; 9(1):47-62.
PMID: 28597152 PMC: 5777974. DOI: 10.1007/s13238-017-0433-3.
Naschberger A, Furnrohr B, Lenac Rovis T, Malic S, Scheffzek K, Dieplinger H Acta Crystallogr D Struct Biol. 2016; 72(Pt 12):1267-1280.
PMID: 27917827 PMC: 5137224. DOI: 10.1107/S205979831601723X.
Huang T, Chen X, Gu H, Zhao C, Liu X, Yan M Oncotarget. 2016; 7(21):31166-76.
PMID: 27145274 PMC: 5058747. DOI: 10.18632/oncotarget.9085.